LALuis Agüera-Ortiz

Luis Agüera-Ortiz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luis Agüera-Ortiz has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Social robots in advanced dementia

    by Meritxell Valentí Soler, Luis Agüera-Ortiz, Javier Olazarán Rodríguez, Carolina Mendoza Rebolledo, Almudena Pérez Muñoz, Irene Rodríguez Pérez, Emma Osa Ruiz, Ana Barrios Sánchez, Vanesa Herrero Cano, Laura Carrasco Chillón, et al.

    Aims: Testing the effect of the experimental robot-based therapeutic sessions for patients with dementia in: a controlled study of parallel groups of nursing home patients comparing the effects of therapy sessions utilizing a humanoid robot (NAO), an animal-shaped robot (PARO), or a trained dog (DOG), with conventional therapy (CONTROL) on symptoms of dementia; and an experience for patients who attend a day care center, comparing symptom prevalence and severity before and after sessions utilizing NAO and PARO. Methods: In the nursing home, patients were randomly assigned by blocks, based on dementia severity, to one of the 3 therapeutic groups to compare: CONTROL, PARO and NAO (phase 1) and CONTROL, PARO and DOG (phase 2). In the day care center, all patients received therapy with NAO (phase 1) and PARO (phase 2). Therapy sessions were held 2 days/week for 3 months. Evaluation at baseline and follow-up was carried out by blind raters using: the Global Deterioration Scale (GDS), the Severe Mini Mental State Examination (sMMSE), the Mini Mental State Examination (MMSE), the Neuropsychiatric Inventory (NPI), the Apathy Scale for Institutionalized Patients with Dementia Nursing Home version (APADEM-NH), the Apathy Inventory (AI) and the Quality of Life Scale (QUALID). Statistical analysis included descriptive statistics and non parametric tests performed by a blinded investigator. Results: In the nursing home, 101 patients (phase 1) and 110 patients (phase 2) were included. There were no significant differences at baseline. The relevant changes at follow-up were: (phase 1) patients in the robot groups showed an improvement in apathy; patients in NAO group showed a decline in cognition as measured by the MMSE scores, but not the sMMSE; the robot groups showed no significant changes between them; (phase 2) QUALID scores increased in the PARO group. In the day care center, 20 patients (phase 1) and 17 patients (phase 2) were included. The main findings were: (phase 1) imp


  • A Novel Rating Scale for the Measurement of Apathy in Institutionalized Persons with Dementia: The APADEM-NH

    by Luis Agüera-Ortiz, Nuria Gil-Ruiz, Isabel Cruz-Orduña, Isabel Ramos-García, Ricardo S. Osorio, Meritxell Valentí-Soler, Javier Olazarán-Rodriguez, José L. Dobato-Ayuso, Krista Lanctôt, Pablo Martínez-Martín


    • 1 January 2015
      • Vol. 60  (1) , 1-9

    [Reliability and validity of the Severe Impairment Battery, short form (SIB-s), in patients with dementia in Spain].

    by Isabel Cruz Orduña, Luis F Agüera-Ortiz, Ignacio Montorio-Cerrato, Beatriz Leon-Salas, M Cristina Valle De Juan, Pablo Martínez-Martín

    People with progressive dementia evolve into a state where traditional neuropsychological tests are not effective. Severe Impairment Battery (SIB) and short form (SIB-s) were developed for evaluating the cognitive status in patients with severe dementia. To evaluate the psychometric attributes of the SIB-s in patients with severe dementia. 127 institutionalized patients (female: 86.6%; mean age: 82.6 ± 7.5 years-old) with dementia were assessed with the SIB-s, the Global Deterioration Scale (GDS), Mini-Mental State Examination (MMSE), Severe Mini-Mental State Examination (sMMSE), Barthel Index and FAST. SIB-s acceptability, reliability, validity and precision were analyzed. The mean total score for scale was 19.1 ± 15.34 (range: 0-48). Floor effect was 18.1%, only marginally higher than the desirable 15%. Factor analysis identified a single factor explaining 68% of the total variance of the scale. Cronbach's alpha coefficient was 0.96 and the item-total corrected correlation ranged from 0.27 to 0.83. The item homogeneity value was 0.43. Test-retest and inter-rater reliability for the total score was satisfactory (ICC: 0.96 and 0.95, respectively). The SIB-s showed moderate correlation with functional dependency scales (Barthel Index: 0.48, FAST: -0.74). Standard error of measurement was 3.07 for the total score. The SIB-s is a reliable and valid instrument for evaluating patients with severe dementia in the Spanish population of relatively brief instruments.


  • Quality of life (QoL) in community-dwelling and institutionalized Alzheimer's disease (AD) patients

    by Beatriz León-Salas, Javier Olazarán, Isabel Cruz-Orduña, Luis Agüera-Ortiz, José Luis Dobato, Meritxell Valentí-Soler, Ruben Muñiz, Ma Teresa González-Salvador, Pablo Martínez-Martín